Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma

Area of Science:

• Oncology
• Epigenetics
• Dermatology

Background:

• Epigenetic alterations are crucial in the pathogenesis of human diseases, notably cutaneous melanoma (CM).
• Unlike genetic mutations, epigenetic modifications are dynamic and reversible, offering potential for therapeutic intervention.
• Aberrant DNA methylation and histone modifications play significant roles in CM initiation and progression.

Purpose of the Study:

• To review the latest research on genetic and epigenetic alterations in cutaneous melanoma.
• To explore the potential of epigenetic modifications as diagnostic and prognostic biomarkers for CM.
• To discuss the therapeutic implications of targeting epigenetic pathways in CM management.

Main Methods:

• Comprehensive literature review of recent findings on genetic and epigenetic alterations in CM.
• Analysis of molecular mechanisms including DNA methylation and histone modifications.
• Evaluation of current epi-therapies and combinatorial approaches in CM treatment.

Main Results:

• Epigenetic changes significantly influence CM genesis and clinical behavior.
• Understanding these alterations can identify novel biomarkers for CM diagnosis and prognosis.
• Epigenetic modifications present promising therapeutic targets for preventing or overcoming drug resistance in CM.

Conclusions:

• Targeting epigenetic alterations in CM offers a pathway to personalized therapeutic strategies.
• Epi-therapies and combinatorial approaches show potential in managing this fatal disease.
• Further research into epigenetic mechanisms is vital for advancing CM clinical management.